HCPro, JustCoding Outpatient - 2022 Issue 24 (June)
Healthcare News: CMS releases new HCPCS code for EVUSHELD COVID-19 treatment
June 10th, 2022
CMS recently announced that it released a new HCPCS Level II code for AstraZeneca's EVUSHELDÂ COVID-19 antibody treatment, effective for dates of service on or after February 24. The initial dose authorized for use during the public health emergency has been changed to 600 mg for pre-exposure prevention of COVID-19.
To read the full article, sign in and subscribe to the JustCoding Newsletters.
Thank you for choosing Find-A-Code, please Sign In to remove ads.